Wenbin Lin, Ph.D., of the University of North Carolina at Chapel Hill, is corresponding author of the study. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...
OCTOBER 27, 2022, NEW YORK – A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results